Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Croker

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
JMIR Medical Informatics|December 20, 2022
Identifying Patterns of Clinical Interest in Clinicians' Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical ReviewBrian MacKenna, Helen J Curtis, Lisa E M Hopcroft, et al.
British Journal of Clinical Pharmacology|May 10, 2023
The impact of lidocaine plaster prescribing reduction strategies: A comparison of two national health services in EuropeMolly Mattsson, Fiona Boland, Ciara Kirke, et al.
The Lancet. Public Health|June 28, 2024
Changes in opioid prescribing during the COVID-19 pandemic in England: an interrupted time-series analysis in the OpenSAFELY-TTP cohortAndrea L Schaffer, Colm D Andrews, Andrew D Brown, et al.
BMJ Mental Health|April 28, 2025
Impact of the COVID-19 pandemic on antidepressant prescribing with a focus on people with learning disability and autism: an interrupted time series analysis in England using OpenSAFELY-TPPChristine Cunningham, Orla Macdonald, Andrea Schaffer, et al.
Open Heart|November 17, 2021
OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic, Helen J Curtis, Brian MacKenna, et al.
Annals of Internal Medicine|May 1, 2023
Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational DataWilliam J Hulme, Elizabeth Williamson, Elsie M F Horne, et al.
BMJ Mental Health|September 15, 2023
Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients' primary care records in situ using OpenSAFELYOrla Macdonald, Amelia Green, Alex Walker, et al.
British Journal of Clinical Pharmacology|April 8, 2024
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rateAndrew D Brown, Louis Fisher, Helen J Curtis, et al.
Nature|July 9, 2020
Factors associated with COVID-19-related death using OpenSAFELYElizabeth J Williamson, Alex J Walker, Krishnan Bhaskaran, et al.
BMJ Medicine|May 28, 2024
Incidence and treatment of group A streptococcal infections during covid-19 pandemic and 2022 outbreak: retrospective cohort study in England using OpenSAFELY-TPPChristine Cunningham, Louis Fisher, Christopher Wood, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
JMIR Medical Informatics|December 20, 2022
Identifying Patterns of Clinical Interest in Clinicians' Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical ReviewBrian MacKenna, Helen J Curtis, Lisa E M Hopcroft, et al.
British Journal of Clinical Pharmacology|May 10, 2023
The impact of lidocaine plaster prescribing reduction strategies: A comparison of two national health services in EuropeMolly Mattsson, Fiona Boland, Ciara Kirke, et al.
The Lancet. Public Health|June 28, 2024
Changes in opioid prescribing during the COVID-19 pandemic in England: an interrupted time-series analysis in the OpenSAFELY-TTP cohortAndrea L Schaffer, Colm D Andrews, Andrew D Brown, et al.
BMJ Mental Health|April 28, 2025
Impact of the COVID-19 pandemic on antidepressant prescribing with a focus on people with learning disability and autism: an interrupted time series analysis in England using OpenSAFELY-TPPChristine Cunningham, Orla Macdonald, Andrea Schaffer, et al.
Open Heart|November 17, 2021
OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic, Helen J Curtis, Brian MacKenna, et al.
Annals of Internal Medicine|May 1, 2023
Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational DataWilliam J Hulme, Elizabeth Williamson, Elsie M F Horne, et al.
BMJ Mental Health|September 15, 2023
Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients' primary care records in situ using OpenSAFELYOrla Macdonald, Amelia Green, Alex Walker, et al.
British Journal of Clinical Pharmacology|April 8, 2024
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rateAndrew D Brown, Louis Fisher, Helen J Curtis, et al.
Nature|July 9, 2020
Factors associated with COVID-19-related death using OpenSAFELYElizabeth J Williamson, Alex J Walker, Krishnan Bhaskaran, et al.
BMJ Medicine|May 28, 2024
Incidence and treatment of group A streptococcal infections during covid-19 pandemic and 2022 outbreak: retrospective cohort study in England using OpenSAFELY-TPPChristine Cunningham, Louis Fisher, Christopher Wood, et al.
Pageof 6